Brief: Oncopeptides' Says CFO Anders Martin-Löf Will Leave Co
Oct 15 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES' CFO ANDERS MARTIN-LÖF WILL LEAVE THE COMPANY
* ANDERS MARTIN-LÖF HAS INFORMED ONCOPEPTIDES THAT HE WILL
LEAVE
COMPANY FOR PERSONAL REASONS
* A RECRUITMENT PROCESS WILL BE INITIATED IMMEDIATELY
* ANDERS HAS SIX-MONTH NOTICE PERIOD, HE WILL CONTINUE IN
HIS
CURRENT ROLE UNTIL A NEW TEMPORARY OR PERMANENT CFO TAKES OFFICE
Source text for Eikon: ID:nWkr263hzV
Further company coverage: ONCO.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy